Elucidating Antiangiogenic Potential of Rauwolfia serpentina: VEGFR-2 Targeting-Based Molecular Docking Study
暂无分享,去创建一个
Sajjad Karim | S. Tabrez | F. Al-Sayes | M. Hoque | Adel M. Abuzenadah | Syed Sahajada Mahafujul Alam | I. M. Hussain
[1] Mohd Saeed,et al. A Comparative Antibacterial, Antioxidant, and Antineoplastic Potential of Rauwolfia serpentina (L.) Leaf Extract with Its Biologically Synthesized Gold Nanoparticles (R-AuNPs) , 2021, Plants.
[2] F. Husain,et al. Identification of butyrylcholinesterase and monoamine oxidase B targeted ligands and their putative application in Alzheimer's treatment: A computational strategy. , 2021, Current pharmaceutical design.
[3] Sanjib K. Das,et al. In-silico based identification of phytochemicals from Houttuynia cordata Thunb. as potential inhibitors for overexpressed HER2 and VEGFR2 cancer genes , 2021, Journal of biomolecular structure & dynamics.
[4] M. Alajmi,et al. Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer’s treatment , 2021, Annals of medicine.
[5] Walaa F. Alsanie,et al. Novel Papaverine Metal Complexes with Potential Anticancer Activities , 2020, Molecules.
[6] N. R. Jabir,et al. In silico screening of glycogen synthase kinase-3β targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer’s disease , 2020, Journal of biomolecular structure & dynamics.
[7] I. Liu,et al. Novel human Ab against vascular endothelial growth factor receptor 2 shows therapeutic potential for leukemia and prostate cancer , 2019, Cancer science.
[8] V. Kulkarni,et al. Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective , 2019, Medicine in Drug Discovery.
[9] K. Ichimura,et al. Anticancer effects of a non-narcotic opium alkaloid medicine, papaverine, in human glioblastoma cells , 2019, PloS one.
[10] Yunjian Zhang,et al. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway , 2019, Journal of Experimental & Clinical Cancer Research.
[11] Wei Li,et al. VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer , 2019, BMC Cancer.
[12] W. Cho,et al. Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer. , 2018, The Cochrane database of systematic reviews.
[13] R. P. Vivek-Ananth,et al. IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry And Therapeutics , 2017, bioRxiv.
[14] A. Bhattacharjee,et al. Molecular docking of the anticancer bioactive compound proceraside with macromolecules involved in the cell cycle and DNA replication. , 2016, Genetics and molecular research : GMR.
[15] Thomas Sander,et al. DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis , 2015, J. Chem. Inf. Model..
[16] A. Bruzzone,et al. Involvement of α2‐ and β2‐adrenoceptors on breast cancer cell proliferation and tumour growth regulation , 2012, British journal of pharmacology.
[17] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[18] Roman A. Laskowski,et al. LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery , 2011, J. Chem. Inf. Model..
[19] S. Greenfield,et al. The use of herbal medicines by people with cancer: a cross-sectional survey , 2011, British Journal of Cancer.
[20] Abhijit Dey,et al. Ethnobotanical aspects of Rauvolfia serpentina (L). Benth. ex Kurz. in India, Nepal and Bangladesh , 2011 .
[21] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[22] A. Bruzzone,et al. Adrenoceptors: non conventional target for breast cancer? , 2009, Current medicinal chemistry.
[23] Z. Wang,et al. Effects of α-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro , 2008 .
[24] C. Lipinski. Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.
[25] A. Logan,et al. Angiogenesis , 1993, The Lancet.
[26] Endar Marraskuranto,et al. In silico study of fucoxanthin as a tumor cytotoxic agent , 2012, Journal of pharmacy & bioallied sciences.
[27] N. Ferrara. Vascular endothelial growth factor: molecular and biological aspects. , 1999, Current topics in microbiology and immunology.
[28] R. Caulfield,et al. Rauwolfia in the treatment of hypertension. , 1955, The Practitioner.